Rheumatology Highlights 2020–2021
Dr. H. Michael Belmont effectively treats a patient with lupus facing thrombocytopenia and anemia.
The studies’ span speaks to NYU Langone’s strong ability to lead multicenter trials in rheumatology.
Studies show immunosuppressants do not significantly alter risk for worse COVID-19 outcomes.
New grant-funded research works to unlock the intricacies of Behcet’s disease.